Search results
Anti-Cancer Drug Pembrolizumab: Frequently Used Alone Or With Other Treatments
Forbes· 1 day agoPembrolizumab, sold as Keytruda by Merck & Co., was one of the first inhibitors to hit the market. A...
TILT Biotherapeutics Presents Clinical Data on TILT-123 in Ovarian Cancer at ASCO 2024
Benzinga· 2 hours agoHELSINKI, Finland, May 28, 2024 (GLOBE NEWSWIRE) -- TILT Biotherapeutics (TILT), a clinical-stage biotechnology company developing cancer immunotherapies, announces that it will present two abstracts at the American
Merus (MRUS) Surges 36% on Head & Neck Cancer Antibody Data
Zacks· 1 day agoData from an earlier cut-off date shows that treatment with Merus' (MRUS) combination therapy achieved a 60% response rate in patients with head and neck cancer.
Why Top 4% Biotech Stock, Merus, Just Catapulted To A Record High
Investor's Business Daily· 4 days agoThe Netherlands-based biotech paired its drug, petosemtamab, with Merck's cancer blockbuster, ...
Hedge Funds Are Loading Up On This Dividend Stock
Benzinga via Yahoo Finance· 16 hours agoThe markets are adjusting to the high interest rates environment, with all the major US stock indices reporting strong gains in May 2024. However, even...
ASCO24: An early look at cancer drug study results
BioPharma Dive via Yahoo Finance· 5 days agoClinical trial abstracts posted Thursday ahead of this year’s ASCO meeting give a peek at anticipated datasets from Immunocore, Merus, J&J and Merck &...
Why Merck (MRK) is a Top Momentum Stock for the Long-Term
Zacks via Yahoo Finance· 6 days agoMerck (MRK) Based in Kenilworth, NJ, Merck & Co. boasts more than six blockbuster products in its...
ASCO 2024: Merus touts positive Phase II data for head and neck cancer antibody
Pharmaceutical Technology via Yahoo Finance· 4 days agoThe Phase II study is evaluating petosemtamab in combination with Merck & Co’s PD-1 inhibitor ...
Ken Griffin Is Snapping Up These Dividend Stocks: Hess And 2 More
Benzinga via Yahoo Finance· 15 hours agoKen Griffin, founder of Citadel in 1990, is widely regarded as a leading figure among contemporary...
Cancer Biotech Stocks Are on the Move Ahead of a Big Event. What to Know.
Barrons.com· 4 days agoThe American Society of Clinical Oncology is set to gather on May 31 in Chicago for its annual...